-- 
Israel Stocks: Strauss, Teva, Ratio, Mazor, Gazit-Globe, Elbit

-- B y   S u s a n   L e r n e r
-- 
2011-10-02T15:12:41Z

-- http://www.bloomberg.com/news/2011-10-02/israel-stocks-teva-ratio-mazor-gazit-globe-elbit-systems.html
Israel ’s TA-25 Index declined for the
first time in four days, retreating 2.2 percent to 1,054.2 at
the 4:30 p.m. close in Tel Aviv. Investors traded about 1.1
billion shekels ($293 million) in shares and convertible
securities, according to Tel Aviv Stock Exchange data.  The following stocks rose or fell today. Symbols are in
parentheses.  Brainsway Ltd. (BRIN)   gained the most since Aug. 31,
climbing 4.7 percent to 17.75 shekels. The maker of devices to
treat neurological disorders said Israel’s Health Ministry
approved its Deep TMS device to treat major depression, bipolar
depression and schizophrenia.  Elbit Systems Ltd. (ESLT)   advanced to the highest level
in almost a month, increasing 1.9 percent to 152.30 shekels.
Israel’s largest non-government defense contractor won a
contract to establish the Defense Ministry’s $280 million
communications equipment project.  Gazit-Globe Ltd. (GLOB)   fell the most since Sept. 19,
sliding 2.9 percent to 37.02 shekels. The property company
raised its holding in Atrium European Real Estate Ltd. to 31
percent.  Mazor Robotics Ltd. (MZOR)   surged the most since May
2009, jumping 22 percent to 3.53 shekels. The maker of surgical
robots signed agreements to sell two of its Renaissance systems
to customers in the U.S. and  Germany .  Ratio Oil Exploration 1992 LP (RATIL)   soared the most
since Feb. 22, increasing 8.8 percent to 0.286 shekel. The
partners in Israel’s largest natural-gas discovery said drilling
at the Leviathan 3 site will be finished in mid-November.
Partners in the project Avner Oil Exploration-LP (AVNRL IT)
climbed 2.8 percent to 1.748 shekels and Delek Drilling-LP
(DEDRL IT) advanced 2.2 percent to 9.69 shekels.  Strauss Group Ltd. (STRS)   fell the most since Aug. 7,
declining 7.4 percent to 45 shekels. The food company that
derived about a fifth of its 2010 revenue from dairy products
said it was cutting the price of some of its  milk products  12
percent.  Teva Pharmaceutical Industries Ltd. (TEVA)   jumped the
most since Dec. 9, adding 5.7 percent to 140.70 shekels, the
equivalent of $37.53. The U.S.-traded shares of the world’s
largest maker of generic drugs closed at $37.22 on Sept. 30.  To contact the reporter on this story:
Susan Lerner in Jerusalem at 
 slerner2@bloomberg.net   To contact the editor responsible for this story:
Claudia Maedler at 
 cmaedler@bloomberg.net  